• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Acquired drug resistance: we can do more than we think!

作者信息

Alffenaar Jan-Willem C, Gumbo Tawanda, Aarnoutse Rob E

机构信息

Department of Clinical Pharmacy and Pharmacology, University of Groningen, University Medical Center Groningen, The Netherlands.

University of Texas Southwestern Medical Centre, Dallas.

出版信息

Clin Infect Dis. 2015 Mar 15;60(6):969-70. doi: 10.1093/cid/ciu1146. Epub 2014 Dec 19.

DOI:10.1093/cid/ciu1146
PMID:25527653
Abstract
摘要

相似文献

1
Acquired drug resistance: we can do more than we think!获得性耐药：我们能做到的比想象中更多！
Clin Infect Dis. 2015 Mar 15;60(6):969-70. doi: 10.1093/cid/ciu1146. Epub 2014 Dec 19.
2
[Extensive drug resistance acquired during treatment of multidrug-resistant tuberculosis].[耐多药结核病治疗期间获得的广泛耐药性]
Med Mal Infect. 2015 Jan-Feb;45(1-2):61-2. doi: 10.1016/j.medmal.2014.10.010.
3
Analysis of Green Light Committee implementation and acquisition of second-line drug resistance.绿灯委员会实施情况及二线耐药性获得情况分析
Clin Infect Dis. 2015 Mar 15;60(6):970. doi: 10.1093/cid/ciu1147. Epub 2014 Dec 19.
4
The surprising diversity of Mycobacterium tuberculosis: change you can believe in.结核分枝杆菌惊人的多样性：你可以相信的变化。
J Infect Dis. 2012 Dec 1;206(11):1642-4. doi: 10.1093/infdis/jis603. Epub 2012 Sep 14.
5
Bedaquiline.贝达喹啉
Br J Clin Pharmacol. 2015 Aug;80(2):182-4. doi: 10.1111/bcp.12613. Epub 2015 Jul 2.
6
Acquired drug resistance during inadequate therapy in a young child with tuberculosis.一名患结核病幼儿在治疗不充分期间出现获得性耐药。
Pediatr Infect Dis J. 2014 Aug;33(8):883-5. doi: 10.1097/INF.0000000000000336.
7
[Reasons for drug-resistant tuberculosis emergence].[耐多药结核病出现的原因]
Zhonghua Jie He He Hu Xi Za Zhi. 2007 Jun;30(6):403-5.
8
[The problems in the chemotherapy of tuberculosis taking into account new data on its causative organism].[考虑到结核病病原体的新数据，结核病化疗中的问题]
Antibiot Khimioter. 2000;45(5):3-5.
9
Acquired drug resistance because of pharmacokinetic variability in a young child with tuberculosis.一名患结核病幼儿因药代动力学变异性导致获得性耐药。
Pediatr Infect Dis J. 2014 Nov;33(11):1205. doi: 10.1097/INF.0000000000000436.
10
In reply: Acquired drug-resistance because of pharmacokinetic variability in a young child with tuberculosis.回复：一名患结核病幼儿因药代动力学变异性导致获得性耐药。
Pediatr Infect Dis J. 2014 Nov;33(11):1205-6. doi: 10.1097/INF.0000000000000404.

引用本文的文献

1
Pharmacokinetics and Safety of Levofloxacin for Treatment of Rifampicin-Resistant Tuberculosis During Pregnancy and the Postpartum Period: Results from IMPAACT P1026s.左氧氟沙星治疗妊娠及产后耐利福平结核病的药代动力学和安全性：IMPAACT P1026s研究结果
Clin Pharmacokinet. 2025 Apr;64(4):619-630. doi: 10.1007/s40262-025-01498-0. Epub 2025 Mar 28.
2
Salivary Therapeutic Drug Monitoring of Antimicrobial Therapy: Feasible or Futile?唾液治疗药物监测在抗菌治疗中的应用：可行还是徒劳？
Clin Pharmacokinet. 2024 Mar;63(3):269-278. doi: 10.1007/s40262-024-01346-7. Epub 2024 Feb 1.
3
Prospective evaluation of improving fluoroquinolone exposure using centralised therapeutic drug monitoring (TDM) in patients with tuberculosis (PERFECT): a study protocol of a prospective multicentre cohort study.
前瞻性评估使用集中式治疗药物监测（TDM）改善结核病患者氟喹诺酮类药物暴露的效果（PERFECT）：一项前瞻性多中心队列研究的研究方案。
BMJ Open. 2020 Jun 16;10(6):e035350. doi: 10.1136/bmjopen-2019-035350.
4
Management of patients with multidrug-resistant tuberculosis.耐多药结核病患者的管理。
Int J Tuberc Lung Dis. 2019 Jun 1;23(6):645-662. doi: 10.5588/ijtld.18.0622.
5
Limited Sampling Strategies Using Linear Regression and the Bayesian Approach for Therapeutic Drug Monitoring of Moxifloxacin in Tuberculosis Patients.线性回归和贝叶斯方法在结核病患者莫西沙星治疗药物监测中的有限采样策略。
Antimicrob Agents Chemother. 2019 Jun 24;63(7). doi: 10.1128/AAC.00384-19. Print 2019 Jul.
6
Evaluation of Saliva as a Potential Alternative Sampling Matrix for Therapeutic Drug Monitoring of Levofloxacin in Patients with Multidrug-Resistant Tuberculosis.评估唾液作为潜在的替代采样基质用于监测耐多药结核病患者左氧氟沙星的治疗药物监测。
Antimicrob Agents Chemother. 2019 Apr 25;63(5). doi: 10.1128/AAC.02379-18. Print 2019 May.
7
Pharmacokinetics of Levofloxacin in Multidrug- and Extensively Drug-Resistant Tuberculosis Patients.左氧氟沙星在耐多药和广泛耐药结核病患者中的药代动力学
Antimicrob Agents Chemother. 2017 Jul 25;61(8). doi: 10.1128/AAC.00343-17. Print 2017 Aug.
8
Determination of bedaquiline in human serum using liquid chromatography-tandem mass spectrometry.采用液相色谱-串联质谱法测定人血清中的贝达喹啉。
Antimicrob Agents Chemother. 2015 Sep;59(9):5675-80. doi: 10.1128/AAC.00276-15. Epub 2015 Jul 6.
9
Limited sampling strategy and target attainment analysis for levofloxacin in patients with tuberculosis.结核病患者左氧氟沙星的有限采样策略与目标达成分析
Antimicrob Agents Chemother. 2015 Jul;59(7):3800-7. doi: 10.1128/AAC.00341-15. Epub 2015 Apr 13.
10
Reply to Soman et al, Alffenaar et al, Metcalfe et al, and Raoult.对索曼等人、阿尔夫费纳尔等人、梅特卡夫等人以及拉乌尔的回复。
Clin Infect Dis. 2015 Mar 15;60(6):971-3. doi: 10.1093/cid/ciu1150. Epub 2014 Dec 19.